Literature DB >> 6991424

New type of antibody-enzyme conjugate which specifically kills Candida albicans.

K Okuda, K Ishiwara, Y Noguchi, T Takahashi, I Tadokoro.   

Abstract

A new type of antibody-enzyme conjugate was made, and its possible application to Candida infection was studied. Both lactoperoxidase and xanthine oxidase were conjugated to specific antibody against Candida albicans. In vitro microbiocidal activity of the new antibody-enzyme conjugate, when incubated together with xanthine and minute amount of halides, showed a remarkable level of candidacidal ability. When the new antibody-enzyme conjugate was given to Candida-infected mice, followed by injecting xanthine and a minute amount of halides, about 50% of these heavily infected mice survived, whereas all control nontreated mice died. These data suggest that the further eleboration of this new antibody-enzyme conjugate might lead us to improve our therapeutic methods of clinical medicine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991424      PMCID: PMC550820          DOI: 10.1128/iai.27.2.690-692.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  5 in total

1.  Studies on milk xanthine oxidase. Some spectral and kinetic properties.

Authors:  V Massey; P E Brumby; H Komai
Journal:  J Biol Chem       Date:  1969-04-10       Impact factor: 5.157

2.  Enzymatic activation and trapping of luminol-substituted peptides and proteins. A possible means of amplifying the cytotoxicity of anti-tumor antibodies.

Authors:  C W Parker; R D Aach; G W Philpott
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

3.  Selective destruction of target cells by diphtheria toxin conjugated to antibody directed against antigens on the cells.

Authors:  F L Moolten; S R Cooperband
Journal:  Science       Date:  1970-07-03       Impact factor: 47.728

4.  Myeloperoxidase-halide-hydrogen peroxide antibacterial system.

Authors:  S J Klebanoff
Journal:  J Bacteriol       Date:  1968-06       Impact factor: 3.490

5.  In vitro antibody-enzyme conjugates with specific bactericidal activity.

Authors:  D M Knowles; T J Sulivan; C W Parker; R C Williams
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

  5 in total
  3 in total

1.  Candidacidal activity of myeloperoxidase: therapeutic influence of the enzyme in vivo.

Authors:  C D Wright; R D Nelson
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

2.  Enzyme immunoconjugates utilizing glucose oxidase and myeloperoxidase are cytotoxic to Candida tropicalis.

Authors:  D Casentini-Borocz; T Bringman
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

3.  Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro.

Authors:  R D Diamond; R A Clark; C C Haudenschild
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.